Edition:
India

Evolent Health Inc (EVH.N)

EVH.N on New York Stock Exchange

7.74USD
25 Jun 2019
Change (% chg)

$-0.52 (-6.30%)
Prev Close
$8.26
Open
$8.27
Day's High
$8.34
Day's Low
$7.70
Volume
368,026
Avg. Vol
365,597
52-wk High
$29.00
52-wk Low
$7.70

Latest Key Developments (Source: Significant Developments)

Evolent Health Qtrly Loss Per Share $0.59
Wednesday, 8 May 2019 

May 7 (Reuters) - Evolent Health Inc ::EVOLENT HEALTH ANNOUNCES FIRST QUARTER 2019 RESULTS.Q1 REVENUE $197.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $192.7 MILLION.QTRLY LOSS PER SHARE $0.59.  Full Article

Evolent Health To Buy New Century Health For Up To $217 Mln
Wednesday, 12 Sep 2018 

Sept 12 (Reuters) - Evolent Health Inc ::EVOLENT HEALTH TO ACQUIRE NEW CENTURY HEALTH, EXPANDING ITS SPECIALTY CARE MANAGEMENT CAPABILITIES.EVOLENT HEALTH INC - EVOLENT TO ACQUIRE NEW CENTURY HEALTH'S BUSINESS FOR UP TO $217 MILLION..EVOLENT HEALTH INC - PURCHASE PRICE CONSISTS OF 3.1 MILLION SHARES OF EVOLENT CLASS B COMMON STOCK AND $120 MILLION IN CASH AT CLOSING.EVOLENT HEALTH INC - SHARES TO BE ISSUED IN RELATION TO EARN-OUT ARE LIMITED TO 1.0 MILLION SHARES WITH FULL PAYMENT EXPECTED TO BE MADE IN Q1 OF 2020.EVOLENT HEALTH INC - SHARES AT CLOSING AND IN EARN-OUT WILL BE ISSUED IN TRANSACTIONS EXEMPT FROM REGISTRATION UNDER SECURITIES ACT OF 1933.EVOLENT HEALTH - PURCHASE PRICE HAS EARN-OUT OF UP TO $20 MILLION, PAYABLE IN CASH AND EVOLENT CLASS B COMMON STOCK, TIED TO FUTURE NEW BUSINESS ACTIVITY.EVOLENT HEALTH INC - EVOLENT WILL CONSOLIDATE RESULTS OF ACQUIRED BUSINESS ONLY FOR PERIOD SUBSEQUENT TO CLOSE OF TRANSACTION.EVOLENT HEALTH INC - EXPECTS ACQUIRED BUSINESS TO GENERATE ADJUSTED REVENUES ABOUT $177 MILLION FOR LATEST TWELVE MONTHS ENDED JUNE 30.  Full Article

Evolent Health QTRLY Loss Per Share $0.13
Wednesday, 8 Aug 2018 

Evolent Health Inc ::EVOLENT HEALTH ANNOUNCES SECOND QUARTER 2018 RESULTS.Q2 REVENUE $144.3 MILLION VERSUS I/B/E/S VIEW $141.8 MILLION.QTRLY LOSS PER SHARE $0.13.FOR FULL YEAR 2018, ADJUSTED REVENUE IS EXPECTED TO BE IN RANGE OF APPROXIMATELY $570.0 MILLION TO $585.0 MILLION.Q2 EARNINGS PER SHARE VIEW $-0.04, REVENUE VIEW $141.8 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Evolent Health Sees Adjusted Services Revenue Growth In Mid-To-High Teens For 2018‍​
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Evolent Health Inc ::EVOLENT HEALTH SAYS ANTICIPATES MEETING OR EXCEEDING ISSUED ADJUSTED REVENUE, ADJUSTED EBITDA GUIDANCE FOR THREE MONTHS ENDED DEC 31, 2017 - SEC FILING.EVOLENT HEALTH SEES ADJUSTED SERVICES REVENUE GROWTH IN MID-TO-HIGH TEENS FOR 2018‍​.EVOLENT HEALTH - ANTICIPATE TRUE HEALTH NEW MEXICO ADJUSTED PREMIUM REVENUE OF ABOUT $95 MILLION-$100 MILLION IN 2018.EVOLENT HEALTH - ANTICIPATE ADJUSTED INTER-COMPANY REVENUES OF ABOUT $20 MILLION IN 2018.  Full Article

Evolent Health And Premier Health Terminate Agreement For Acquisition Of Premier Health Plan
Friday, 8 Dec 2017 

Dec 8 (Reuters) - Evolent Health Inc ::EVOLENT HEALTH AND PREMIER HEALTH ANNOUNCE TERMINATION OF AGREEMENT FOR ACQUISITION OF PREMIER HEALTH PLAN.EVOLENT HEALTH AND PREMIER HEALTH ANNOUNCE TERMINATION OF AGREEMENT FOR ACQUISITION OF PREMIER HEALTH PLAN.- TWO PARTIES WERE UNABLE TO REACH TERMS ON RELATED PARTY AGREEMENTS..‍PREMIER CONTINUES TO EXPLORE STRATEGIC OPTIONS FOR ITS HEALTH PLAN BUSINESS​.EVOLENT HEALTH -CO TO CONTINUE TO PROVIDE SUPPORT SERVICES WITH EXISTING ADMINISTRATIVE AGREEMENT FOR EMPLOYEE SELF-INSURED, MEDICARE ADVANTAGE.  Full Article

Evolent Health announces third quarter 2017 results
Friday, 3 Nov 2017 

Nov 2 (Reuters) - Evolent Health Inc :Evolent Health announces third quarter 2017 results.Q3 revenue $107.9 million versus I/B/E/S view $104.5 million.Evolent Health Inc - ‍for three months ended December 31, 2017, adjusted revenue is expected to be in range of $110.0 million to $112.0 million​.Evolent Health Inc qtrly loss per share $0.18​.Evolent Health Inc - ‍for full year 2017, we expect adjusted revenue to be in range of $432.0 million to $434.0 million​.Evolent Health Inc - ‍for full year 2017, adjusted EBITDA to be in range of loss of $3.0 million to loss of $2.0 million.Evolent Health Inc - ‍ for three months ended December 31, 2017, adjusted EBITDA is expected to be in range of $3.0 million to $4.0 million​.FY2017 revenue view $427.2 million -- Thomson Reuters I/B/E/S.Q4 revenue view $108.9 million -- Thomson Reuters I/B/E/S.  Full Article